Latest Software News

Norwood Systems has reported a record preliminary revenue of $2.1 million for the first half of FY2026, driven by milestone payments from Optus and a successful Tier-1 APAC proof-of-concept. The company is progressing multiple global telco engagements and strengthening strategic partnerships with Microsoft and AWS.

RPMGlobal has secured a crucial Foreign Investment Review Board approval for its proposed acquisition by Caterpillar, marking a significant step forward in the takeover process.

RocketDNA’s December quarter saw a robust 32% revenue jump, underpinned by new contracts with mining giants BHP and Anglo American, signalling strong momentum for 2026.

Ovanti Limited has completed a $1 million capital raise through a discounted share placement to accelerate its buy now, pay later business expansion in the United States.

Genetic Signatures reported a $3.3 million quarterly revenue with growing international sales and a robust cash position, while preparing for a leadership change.

4DMedical Limited has raised AU$150 million to accelerate the commercial rollout of its FDA-cleared CT, VQ lung imaging technology in the US, leveraging a strategic partnership with Philips. This funding aims to expand adoption across major medical centres and government healthcare programs.

Knosys’ Greenorbit subsidiary has inked a two-year agency deal with UK-based Oak Engage to offer its advanced intranet platform to existing Greenorbit customers, marking a strategic shift in Knosys’ product focus.

Global Health Limited reports a robust 23% increase in customer receipts and an 85% jump in quarterly operating cashflow, as it advances its transition to AI-enabled SaaS platforms targeting profitability by June 2026.

A few stocks did the heavy lifting this week, with one biotech exploding higher and a gas name collapsing on the other side of the ledger. Big moves came from capital raises, regulator decisions, and drill results that investors treated as near-term value, not distant promises.

4DMedical Limited has raised $150 million through a well-supported institutional placement to accelerate the commercialisation of its innovative lung imaging product CT – VQ™ in the US market. The capital raise comes with minimal dilution and increased insider confidence.

Alcidion Group has been named preferred supplier for a major UK hospital's Electronic Patient Record system, driving a 40% jump in contracted revenue and a robust cash position in Q2 FY26.

Vitrafy Life Sciences has secured a 12-month exclusive partnership with global animal reproduction leader IMV Technologies to co-develop and commercialise next-generation cryopreservation solutions for farm animals and aquaculture.